AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Bhagirathbhai Dholaria, MD
Vanderbilt University Medical Center and a physician at the Nashville VA Medical Center
Bhagirathbhai Dholaria, MD, is an associate professor of medicine in the Department of Hematology-Oncology at Vanderbilt University Medical Center and a physician at the Nashville VA Medical Center, with a focus on stem cell transplant and cellular immunotherapy. His primary research is adoptive cellular therapy, including CAR T-cell therapy, for relapsed lymphoid and plasma cell malignancies, and he studies biomarkers of CAR T-cell toxicity and novel agents to address relapse after CAR-T in lymphoma and myeloma. He trained at Moffitt Cancer Center before joining Vanderbilt and received an ASCO Conquer Cancer Foundation Merit Award.
Published Articles (1)
October 28, 2026
CAR-T cures fewer than half of patients with relapsed large B-cell lymphoma, and outcomes after CAR-T failure depend heavily on when relapse occurs